# FDA UNTITLED_LETTER - LeeSar, Inc. - June 17, 2022

Source: https://www.globalkeysolutions.net/records/untitled_letter/leesar-inc/a3af623c-849a-4645-8cdf-1e4dd1cafbe2

> FDA UNTITLED_LETTER for LeeSar, Inc. on June 17, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: LeeSar, Inc.
- Inspection Date: 2022-06-17
- Product Type: Drugs

## Related Documents

- [WARNING_LETTER - 2017-07-12](https://www.globalkeysolutions.net/records/warning_letter/leesar-inc/53067d10-0f84-4d3d-b62d-c714eb59e79d)

## Related Officers

- [Program Expert](https://www.globalkeysolutions.net/people/jose-r-lopez/90b67bee-f6bc-4d47-9949-fa96f3aae85d)

Company: https://www.globalkeysolutions.net/companies/leesar-inc/f4821188-033f-452e-8c58-6e417c412753